Edwards Lifesciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EW and other ETFs, options, and stocks.

About EW

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. 

CEO
Bernard J. Zovighian
CEOBernard J. Zovighian
Employees
15,800
Employees15,800
Headquarters
Irvine, California
HeadquartersIrvine, California
Founded
1958
Founded1958
Employees
15,800
Employees15,800

EW Key Statistics

Market cap
48.54B
Market cap48.54B
Price-Earnings ratio
35.62
Price-Earnings ratio35.62
Dividend yield
Dividend yield
Average volume
3.96M
Average volume3.96M
High today
$85.00
High today$85.00
Low today
$83.00
Low today$83.00
Open price
$84.42
Open price$84.42
Volume
2.85M
Volume2.85M
52 Week high
$87.89
52 Week high$87.89
52 Week low
$65.94
52 Week low$65.94

Stock Snapshot

The current Edwards Lifesciences(EW) stock price is $83.00, with a market capitalization of 48.54B. The stock trades at a price-to-earnings (P/E) ratio of 35.62.

On 2026-01-25, Edwards Lifesciences(EW) stock moved within a range of $83.00 to $85.00. With shares now at $83.00, the stock is trading 0.0% above its intraday low and -2.4% below the session's peak.

Trading activity shows a volume of 2.85M, compared to an average daily volume of 3.96M.

Over the past 52 weeks, Edwards Lifesciences(EW) stock has traded between a high of $87.89 and a low of $65.94.

Over the past 52 weeks, Edwards Lifesciences(EW) stock has traded between a high of $87.89 and a low of $65.94.

EW News

Simply Wall St 3d
What Edwards Lifesciences's Court-Blocked JenaValve Deal and Transcatheter Progress Mean For Shareholders

Earlier in January, Edwards Lifesciences said a U.S. court granted the FTC’s request to block its planned acquisition of JenaValve, while the company continued...

What Edwards Lifesciences's Court-Blocked JenaValve Deal and Transcatheter Progress Mean For Shareholders
TipRanks 4d
Venus Medtech Flags U.S. Patent Suit Over Heart Valve Technology Targeting Edwards Lifesciences

Claim 50% Off TipRanks Premium Venus Medtech (Hangzhou), Inc. Class H ( (HK:2500) ) has shared an announcement. Venus Medtech (Hangzhou) Inc. has informed sha...

Simply Wall St 4d
Edwards Lifesciences Valuation Check After Mixed Share Price Momentum And Premium P/E

Advertisement Why Edwards Lifesciences (EW) Is On Investors’ Radar Today Edwards Lifesciences (EW) is drawing attention after a period where the stock showed...

Edwards Lifesciences Valuation Check After Mixed Share Price Momentum And Premium P/E

Analyst ratings

69%

of 35 ratings
Buy
68.6%
Hold
31.4%
Sell
0%

More EW News

TipRanks 5d
Edwards Lifesciences price target raised to $110 from $105 at Stifel

Stifel raised the firm’s price target on Edwards Lifesciences (EW) to $110 from $105 and keeps a Buy rating on the shares, reporting that the firm’s fifty physi...

People also own

Based on the portfolios of people who own EW. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.